Can We Really Slow Aging and Live Longer? What the Latest Geroscience Research Says About Rapamycin, Metformin, and More

Table of Contents

• Key Points
• Introduction: The Promise of Anti-Aging Drugs
• Why Antioxidants Failed to Extend Life
• The Real Goal of Geroscience
• Healthspan vs. Lifespan: What's the Difference?
• If It Doesn't Work in Mice, Why Would It Work in Humans?
• Resveratrol: The Red Wine Compound That Fell Short
• Rapamycin: The Standout Drug
• Curcumin, Quercetin, Spermidine, Berberine, and Fisetin
• NAD Boosters: Promising or Overhyped?
• Metformin: The Diabetes Drug with Mixed Results
• Other Drugs That Extended Lifespan in Mice
• Interpreting the Mouse Data
• Gerostatics: A New Class of Anti-Aging Drugs
• How to Test Anti-Aging Drugs Without Waiting a Lifetime
• Limitations and Caveats
• What This Means for Patients
• Frequently Asked Questions
• Source Information

Key Points

• Rapamycin consistently extends lifespan in mice, including both sexes and many strains.
• Resveratrol, curcumin, and quercetin have not been shown to extend lifespan in mammals.
• NAD boosters like NR and NMN showed no lifespan benefit in normal mice.
• Metformin's mouse data are mixed; it extended lifespan in some strains but shortened it in others.
• The author argues that drugs failing to extend lifespan in mice are unlikely to work in humans.

Introduction: The Promise of Anti-Aging Drugs

Back in 2010, a landmark paper opened with these words: "Although we do not know everything about aging, we now know enough to start its pharmacologic suppression using clinically approved drugs." Over a decade later, that statement still holds true, according to this new research perspective by Dr. Mikhail V. Blagosklonny of Roswell Park Cancer Institute.

The author's approach is grounded in the hyperfunction theory of aging, which proposes that aging is not simply wear-and-tear damage, but rather a continuation of growth and development gone awry. In this view, growth-promoting pathways in the body—especially the mTOR pathway (a cellular "master switch" that regulates growth and metabolism)—remain inappropriately active later in life, driving age-related diseases like cancer, heart disease, and Alzheimer's.

If that sounds technical, here's the takeaway: the author believes we already have drugs that can slow this process. The key question is which drugs actually work—and the evidence, he argues, points strongly to one clear champion.

Why Antioxidants Failed to Extend Life

You've probably heard that antioxidants—like vitamins C and E, beta-carotene, and selenium—can fight aging by neutralizing harmful molecules called reactive oxygen species (ROS). The logic seems simple: if ROS cause molecular damage, and damage causes aging, then antioxidants should slow aging.

But the evidence tells a very different story. The author points out that while knocking out antioxidant enzymes in animals can shorten lifespan, giving extra antioxidants does not extend it. Even worse:

• Clinical trials of antioxidants in humans have actually shown increased mortality
• Some trials were terminated early because of increased cancer incidence
• Antioxidants were shown to promote cancer in mice

Why? According to the author, ROS do cause molecular damage, but no organism lives long enough to die from that damage alone. The hyperfunctional, mTOR-driven aging process "terminates life first." In other words, you cannot extend life by fixing a problem that isn't the one actually killing you. "We cannot extend life by targeting a non-life-limiting process," he writes.

The Real Goal of Geroscience

The geroscience hypothesis holds that aging itself is the root cause of most chronic diseases, so by slowing aging, you can simultaneously prevent or delay many diseases. The author embraces this concept but extends it: the ultimate goal of geroscience is life extension achieved through health extension.

This is an important distinction. Standard medical interventions can extend life without improving health—for example, putting a comatose patient on a ventilator. But anti-aging interventions are different: they extend life by slowing the aging process and thereby delaying all age-related diseases at once.

Healthspan vs. Lifespan: What's the Difference?

Healthspan is defined as the period of life free of age-related diseases. It's essentially "disease-free survival." And here's where the author takes a strong stance: if a drug genuinely increases healthspan, it must also increase lifespan—because animals and humans don't die from good health; they die from diseases. If diseases are delayed, the animal lives longer.

So how do some studies claim that drugs like resveratrol, senolytics, or NAD boosters improve healthspan without extending lifespan? The author offers several explanations:

1. They may not actually improve healthspan at all. Many studies use "ambiguous or irrelevant markers of health" that can be associated with either good or bad health depending on the underlying cause.
2. Some diseases are not deadly. Treating non-fatal conditions can improve quality of life without extending lifespan, and healthspan should not be measured only by such conditions.
3. Some age-related changes are not life-limiting. For example, accumulation of mitochondrial DNA mutations, telomere shortening, and NAD+ depletion may never reach a lethal threshold during a normal lifetime, because hyperfunctional aging kills the organism first.

This last point matters. These "non-limiting" deteriorations can become lethal if normal aging is dramatically slowed. So there's an exciting possibility: once a true anti-aging drug like rapamycin decelerates aging, adding a "healthspan-only" drug might extend life even further—because the organism may now live long enough for those other deteriorations to become relevant.

If It Doesn't Work in Mice, Why Would It Work in Humans?

Here's the author's central argument: if a drug doesn't extend lifespan in mammals like mice, there's no reason to think it will work in humans.

Consider calorie restriction (CR), the best-studied longevity intervention. It extends lifespan in mice, rats, and even monkeys. Even then, some gerontologists debate whether it would extend life in humans. But imagine if CR didn't extend lifespan in any mammal—would anyone suggest it might "mysteriously" work only in humans? Of course not. Yet that's exactly what happens with drugs that fail to extend life in mice but are still promoted for human longevity.

To reasonably expect a drug to extend human lifespan, it must at minimum extend median and maximum lifespan in genetically heterogeneous mice, multiple strains of mice, and cancer-prone mice.

Resveratrol: The Red Wine Compound That Fell Short

Resveratrol—the compound found in red wine and grapes—has been one of the most hyped anti-aging molecules. But the evidence is disappointing:

• Three studies in mice failed to show life extension by resveratrol.
• In one of those studies, resveratrol improved health markers but did not extend lifespan.
• In Wistar rats, pharmacological doses of resveratrol delayed vascular aging but did not extend lifespan.
• The famous 2006 study that seemed to show resveratrol extending lifespan actually involved mice on a high-calorie diet (HCD). The HCD shortened lifespan by increasing early death, and resveratrol prevented that shortening—but it did not extend lifespan beyond what a normal standard diet provided.

In other words, resveratrol may reverse life-shortening caused by a poor diet, but it does not extend normal lifespan. The author notes that this is like giving insulin to animals dying prematurely from type 1 diabetes—it extends their lives, but insulin is not an anti-aging drug. In fact, insulin is "pro-aging rather than anti-aging."

Rapamycin: The Standout Drug

If there is one clear winner in this review, it's rapamycin. Originally developed as an immunosuppressant and anti-cancer drug, rapamycin inhibits the mTORC1 complex—the very pathway the author believes drives aging.

Since 2009, dozens of studies have shown that rapamycin:

• Extends median and maximum lifespan in both males and females
• Works in all strains of normal mice tested
• Works in some cancer-prone and short-lived mice
• Extends life whether given at old or young age, constantly with food, intermittently, or even transiently
• More than doubled lifespan in some short-lived mutant mice
• Shows a dose-response effect: the higher the dose, the longer the lifespan

There is one notable exception: rapamycin slightly shortened lifespan in artificial mice lacking telomerase that failed to grow and died young—but not from aging. This actually supports the theory: rapamycin slows growth and cell proliferation, which is harmful during developmental growth failure, but beneficial later in life when growth pathways drive aging.

The author emphasizes that rapamycin has only one molecular target (mTORC1), and that this pathway is intimately involved in aging and age-related diseases. He also notes that rapamycin's anti-aging properties were predicted before they were shown in any animal—a mark of a solid theory.

Curcumin, Quercetin, Spermidine, Berberine, and Fisetin

Curcumin

Curcumin, the active compound in turmeric, has not fared well in longevity studies. Fed to mice beginning at 12 months of age, it did not extend lifespan in male F1 hybrid mice. In genetically heterogeneous mice, curcumin given from 4 months of age had no effect on lifespan in either sex. The author's conclusion is blunt: "Curcumin never was shown to extend lifespan in any mammals."

Quercetin

Quercetin, a plant flavonoid found in many fruits and vegetables, actually decreased lifespan in mice when given as a 0.1% dietary supplement in a 1982 study—a result that remains undisputed. A later study starting quercetin at 12 months of age also showed no lifespan extension in male F1 hybrid mice.

However, a senolytic combination of quercetin with dasatinib (a cancer drug) did increase median lifespan by 6.3% in C57BL/6 mice. The treatment started at 24–27 months of age (very old for a mouse) and was given every 2 weeks by oral gavage for 3 consecutive days. Notably, quercetin alone was not tested in that study.

Spermidine

Spermidine, a natural polyamine found in all organisms and human food, did not extend median or maximum lifespan in middle-aged male Sprague-Dawley rats—even though it increased "healthspan." In C57BL/6J female mice, spermidine increased medium (but not maximum) lifespan by approximately 10%, whether given lifelong or only late in life.

Berberine

Berberine, a compound found in several plants used in traditional medicine, extended lifespan in C57BL/6J male mice in one study. Of note, berberine inhibits the mTOR pathway in cell culture, giving it a plausible mechanism of action.

Fisetin

Fisetin, a flavonoid found in strawberries and other produce, slightly extended lifespan in old mice—but the study used only a few mice, making the results far from conclusive.

NAD Boosters: Promising or Overhyped?

NAD+ boosters—molecules like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—have become extremely popular supplements claimed to fight aging. The evidence base, however, is thin.

• Nicotinamide riboside (NR) extends lifespan in mice by 4.7%, a result that was only marginally statistically significant (P = 0.034). This is the best result so far for this class of drugs.
• Nicotinamide (NAM), at low and high doses, did not extend lifespan in male C57BL/6J mice on standard or high-fat diets.
• NAD boosters dramatically increased lifespan in short-lived mice with progeroid syndromes (premature aging diseases)—but these mice die young from specific pathologies like liver fibrosis and bone marrow failure, not from normal aging.
• There was no benefit of NR or NMN in normal mice.

This pattern should sound familiar by now: a drug that rescues a specific disease or deficiency in short-lived animals is not necessarily an anti-aging drug for healthy animals.

Metformin: The Diabetes Drug with Mixed Results

Metformin, the world's most prescribed diabetes drug, has been widely discussed as a potential longevity drug. But the mouse data are surprisingly inconsistent. The results depend heavily on the strain of mouse, sex, age, and dose:

• In inbred 129/Sv mice given 100 mg/kg in drinking water: male lifespan decreased by 13.4%, while female lifespan increased by 4.4%
• In female SHR mice: mean lifespan increased by 37.8%, and maximum lifespan increased by 10.3%
• Starting metformin early in life also increased lifespan in female SHR mice
• In another study, metformin alone had no effect on lifespan, but combining it with a sirtuin activator (SRT1720) actually decreased lifespan
• Giving metformin to newborn mice (on days 3, 5, and 7 after birth) extended lifespan in males but not females
• A famous study titled "Metformin improves healthspan and lifespan in mice" showed that a low dose (0.1% w/w in diet) slightly extended lifespan in C57BL/6 male mice, while a higher dose (1% w/w) considerably decreased lifespan
• In genetically heterogeneous mice, metformin at 0.1% w/w did not extend lifespan
• Metformin combined with rapamycin (14 ppm) robustly extended lifespan—but rapamycin alone was not tested in that study
• Metformin did increase lifespan in cancer-prone HER-2/neu transgenic mice in two studies

In humans, however, retrospective and prospective studies indicate that metformin decreases all-cause mortality in patients taking it for various conditions, and it also reduces the incidence of cancer.

The author's summary: metformin consistently extends lifespan in short-lived, cancer-prone mice, but in normal mice its effects are inconsistent, ranging from life extension to life shortening due to toxicity at higher doses. This means the ideal dose in humans matters enormously.

Other Drugs That Extended Lifespan in Mice

17-Alpha-Estradiol

17-alpha-estradiol (17aE2), a weak estrogen, robustly extended both median and maximal lifespan in mice—but only in males.

Acarbose

Acarbose, an alpha-glucosidase inhibitor used to treat type 2 diabetes, blocks digestion of complex carbohydrates. It increased median longevity in males and 90th-percentile lifespan (a measure of maximum lifespan) in both sexes. The author notes this is essentially the drug equivalent of a carbohydrate-free or ketogenic diet, and suggests low-carb diets might be combined with rapamycin for added benefit.

Enalapril and Related Blood Pressure Drugs

ACE inhibitors (like enalapril, lisinopril, and ramipril) and ARBs (like losartan, telmisartan, and valsartan) are widely used to treat hypertension, heart failure, coronary artery disease, diabetes, and chronic kidney disease. They also appear to extend life:

• In 1993, enalapril was shown to increase survival in mice at various doses
• Losartan and enalapril prolonged lifespan in Wistar rats: all control rats died by age 28 months, while 62% of treated rats were still alive. Mean survival increased by 21% (enalapril) and 19% (losartan), both with p < 0.001
• Enalapril also increased lifespan in Wistar rats on standard and high-fat palatable diets
• Ramipril combined with simvastatin (a statin) extended lifespan in long-lived B6C3F1 male mice, although ramipril alone did not
• In humans, ACE inhibitors decrease all-cause mortality in patients with various diseases
• Disrupting the angiotensin II type 1 receptor increases median and maximum lifespan in mice by 26%

The author suggests a combination of rapamycin with metformin, aspirin, ACE inhibitors, and other drugs deserves serious investigation.

Interpreting the Mouse Data

Despite hundreds of reviews touting a "wide arsenal" of emerging anti-aging drugs, the reality is that most of these drugs either do not extend lifespan in mice, or the data are not sufficient to draw conclusions. The author's summary:

• Resveratrol: does not extend lifespan in mammals in any study
• Curcumin and quercetin: not shown to prolong lifespan in mice or rats
• Rapamycin: stands alone—extends lifespan in all numerous studies in normal mice and doubles lifespan in several short-lived mice

One crucial distinction the author draws is between drugs that merely reverse life-shortening (like resveratrol counteracting a high-calorie diet) and drugs that genuinely slow aging. Reversing life-shortening does not imply anti-aging activity. The analogy: giving insulin to a type 1 diabetic animal extends its life, but insulin is not an anti-aging drug—it's a pro-aging hormone.

Gerostatics: A New Class of Anti-Aging Drugs

The author introduces the concept of gerostatics—drugs that decelerate the conversion of normal cells into senescent cells (cells that have stopped dividing but linger and cause inflammation). Unlike senolytics (like the quercetin/dasatinib combination), which kill senescent cells, gerostatics slow down their creation in the first place.

Gerostatics were predicted by the hyperfunction theory of aging. They include:

• Rapamycin and other rapalogs (e.g., everolimus)
• Inhibitors of the mTOR kinase (pan-mTOR inhibitors)
• S6K inhibitors
• PI3K inhibitors
• MEK inhibitors
• MDM-2 inhibitors

Although their gerostatic properties were described more than a decade ago, most haven't been tested for life extension in mammals. One exception: a MEK inhibitor (a clinically available cancer drug) extends lifespan in fruit flies, but its effects on longevity haven't been tested in mice.

The author's prediction: a combination of low doses of pan-mTOR and MEK inhibitors with high doses of rapamycin could extend life further than rapamycin alone. "That could be the next important advance in the anti-aging field since the discovery of anti-aging properties of rapamycin."

How to Test Anti-Aging Drugs Without Waiting a Lifetime

In humans, conducting lifelong clinical trials to directly measure lifespan is nearly impossible. Even if such trials started today, only the next generation would benefit. The author argues we don't need them—at least not for drugs that already meet two criteria:

1. They consistently and significantly extend lifespan in mice (and other mammals, if tested)
2. They are already approved for any indication in humans

Both rapamycin and metformin, for example, are FDA-approved for other uses. Instead of waiting for lifelong trials, the author proposes surrogate lifespan trials: test anti-aging drugs by treating and preventing age-related diseases themselves. Since aging is "a sum of all age-related diseases," delaying those diseases automatically increases lifespan. Anti-aging drugs like rapamycin are thought to be more effective for disease prevention than for treatment after the disease has developed.

While treating one age-related disease, an anti-aging drug should simultaneously delay progression of other diseases (like cancer and Alzheimer's), syndromes (like frailty), and even cosmetic signs of aging (gray hair and wrinkled skin).

Limitations and Caveats

This is a research perspective, not a clinical trial or systematic review. It represents one scientist's strongly held viewpoint, and some of its claims are controversial. Important limitations to keep in mind:

• No human longevity data exist for any of these drugs. The argument relies entirely on extrapolation from mouse studies.
• The author's call to use drugs like rapamycin in healthy humans without further clinical trials is a personal opinion and is not mainstream medical consensus.
• Some results cited are from single studies with small numbers of animals (e.g., fisetin).
• Metformin's effects in mice were highly inconsistent and sometimes harmful (13.4% lifespan reduction in male 129/Sv mice; decreased lifespan at higher doses).
• Rapamycin itself is an immunosuppressant, and its long-term use in healthy people carries potential risks, including increased susceptibility to infections, metabolic changes, and impaired wound healing.
• The author's conclusion that increased healthspan must automatically increase lifespan rests on a specific definition of healthspan as "disease-free survival." Subjective well-being and symptom relief are explicitly excluded from this definition.
• Many age-related changes (mitochondrial DNA mutations, telomere shortening, NAD+ depletion) may become lethal only if normal aging is first slowed—meaning "healthspan-only" drugs might only help after a true anti-aging drug is already working.

What This Means for Patients

If you're a patient or health-conscious reader wondering what to do with this information, here are practical takeaways based on the article:

1. Be skeptical of supplements claiming to extend lifespan. Resveratrol, curcumin, quercetin, NAD boosters, and spermidine have not been shown to extend lifespan in normal mice—and the author argues that's a strong reason to doubt they'll extend human lifespan.
2. Do not take rapamycin or metformin for anti-aging without your doctor's guidance. These are prescription drugs with real side effects. The author's argument is academic; translating it into practice requires careful medical supervision.
3. Pay attention to already-approved medications with longevity evidence. If you have hypertension, heart failure, diabetes, or kidney disease, ACE inhibitors and metformin are already part of standard care—and the data reviewed here suggest they may offer longevity benefits as a bonus.
4. Consider lifestyle interventions. Acarbose is essentially a pharmaceutical way to mimic a low-carbohydrate diet. The author notes low-carb diets may increase lifespan and can be combined with rapamycin conceptually. Calorie restriction remains the gold-standard longevity intervention in animal studies.
5. Watch for future research on combinations. The most exciting possibility raised here is that combining rapamycin with other drugs (metformin, ACE inhibitors, MEK inhibitors) could extend life further than any single drug alone.
6. Understand the healthspan/lifespan trap. If a product claims to improve "healthspan" but cannot demonstrate lifespan extension in animals, ask why. By the author's logic, genuine healthspan improvements must lead to lifespan extension—so the absence of lifespan data is a red flag.

Ultimately, this paper offers real hope: the drugs that could slow human aging may already be sitting in our pharmacies. But translating that hope into safe, effective treatment requires rigorous science, careful clinical judgment, and a healthy dose of patience.

Frequently Asked Questions

What is the difference between healthspan and lifespan?

Healthspan is the period of life free of age-related diseases. Lifespan is how long you live. The article argues that if a drug genuinely improves healthspan by delaying diseases, it must also extend lifespan, because people die from diseases, not from good health. Some drugs may improve quality of life without extending lifespan if they only treat non-fatal conditions.

Does resveratrol extend lifespan?

In mouse studies, resveratrol did not extend lifespan. One study showed it improved health markers but not lifespan. Another found it prevented life-shortening caused by a high-calorie diet, but did not extend lifespan beyond a normal diet. The article concludes resveratrol has not been shown to extend lifespan in any mammal.

What is rapamycin and why is it considered a standout anti-aging drug?

Rapamycin is an immunosuppressant and anti-cancer drug that inhibits the mTORC1 pathway. Since 2009, multiple studies have shown it extends median and maximum lifespan in both male and female mice, across many strains, and even in some short-lived mice. It extends life whether given early or late, and higher doses produce greater effects. It doubled lifespan in some mice.

Does metformin extend lifespan in mice?

Metformin's effects in mice are mixed and depend on strain, sex, age, and dose. For example, it decreased male lifespan in one study and increased female lifespan in another. It extended lifespan in female SHR mice and in cancer-prone mice. However, in normal mice, results ranged from life extension to life shortening. In humans, it may lower all-cause mortality, but the ideal dose matters.

Do NAD boosters like NMN and NR extend lifespan?

Nicotinamide riboside (NR) extended mouse lifespan by 4.7%, a result that was only marginally significant. Nicotinamide (NAM) did not extend lifespan in male mice. NAD boosters increased lifespan in short-lived mice with progeroid syndromes, but not in normal mice. The article states there was no benefit of NR or NMN in normal mice.

Are anti-aging supplements like curcumin, quercetin, and spermidine effective?

Curcumin has not been shown to extend lifespan in any mammal. Quercetin decreased lifespan in one mouse study and had no effect in another. Spermidine did not extend lifespan in rats, but increased medium lifespan in female mice. Fisetin slightly extended lifespan in a small study. These supplements have not demonstrated consistent lifespan extension in animals.

Should I take rapamycin or metformin for anti-aging?

No. Rapamycin and metformin are prescription drugs with real side effects. The article's argument is academic and not mainstream medical advice. Rapamycin can suppress immunity and impair wound healing. Metformin has toxic effects at high doses. Always consult your doctor before using any medication for anti-aging. Do not self-medicate.

Should I get a second opinion before taking rapamycin or metformin for anti-aging?

Before taking rapamycin or metformin for anti-aging, a second opinion can help you weigh the evidence. These are prescription drugs with real side effects; rapamycin is an immunosuppressant and may increase infection risk, impair wound healing, and alter metabolism. No human longevity data exist for these drugs, and extending mouse findings to humans is controversial. A second opinion can clarify whether your personal health profile makes off-label use advisable or whether safer alternatives, including lifestyle changes, are more appropriate. Diagnostic Detectives Network provides independent expert second opinions.

Source Information

Original Article: "The goal of geroscience is life extension"

Author: Mikhail V. Blagosklonny, Roswell Park Cancer Institute, Buffalo, NY, USA

Journal: Oncotarget, 2021, Vol. 12, No. 3, pp. 131–144

Publication Dates: Received December 23, 2020; Accepted January 13, 2021; Published February 2, 2021

Keywords: aging; longevity; rapamycin; mTOR; metformin

Copyright: © 2021 Blagosklonny. Open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Note: This patient-friendly article is based on peer-reviewed research and is intended for educational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.